Novartis Sues Lupin To Protect Diovan Patent
Novartis Pharmaceuticals Corp. went after Lupin Ltd. in New Jersey federal court on Friday, accusing its pharmaceutical rival of infringing the patent used in hypertension treatment Diovan HCT in its attempts...To view the full article, register now.
Already a subscriber? Click here to view full article